Yunan Huang
yunanhuang.bsky.social
Yunan Huang
@yunanhuang.bsky.social
Excited to share our new work using real world data and a target trial emulation to evaluate pre transplant dual therapy with #GLP1RA plus #SGLT2i in solid organ transplant candidates with #Obesity and #Type2Diabetes

advanced.onlinelibrary.wiley.com/doi/10.1002/...
Effectiveness of Pre‐Transplant Dual GLP‐1 Receptor Agonist and SGLT2 Inhibitor Therapy on All‐Cause Mortality in Organ Transplantation Candidates with Obesity and Type 2 Diabetes: a Target‐Trial Emul...
This target trial emulation in solid organ transplant candidates with obesity and type 2 diabetes evaluates whether pre-transplant dual therapy with GLP-1 receptor agonists plus SGLT2 inhibitors is a....
advanced.onlinelibrary.wiley.com
December 14, 2025 at 2:28 AM
Read our latest research on anti-obesity medications and eye health, published in Com Med, rdcu.be/eyVst shows #Tirzepatide & #Semaglutide have superior ocular safety vs traditional obesity drugs
#Obesity #GLP1RA
Comparative ocular outcomes of tirzepatide versus other anti-obesity medications in people with obesity
Communications Medicine - Huang et al. analyze matched adults with obesity receiving Tirzepatide, Semaglutide, Phentermine/Topiramate, Naltrexone/Bupropion, or Phentermine monotherapy. Iirzepatide...
rdcu.be
August 12, 2025 at 9:59 AM
Reposted by Yunan Huang
A study in Nature Communications quantifies how rising temperatures linked to climate change would increase the severity of obstructive sleep apnea (OSA) and reports projected losses of healthy life years and workplace productivity due to OSA. go.nature.com/3HMqsMg #medsky 🧪
June 27, 2025 at 1:13 AM